Can you get tirzepatide on a private prescription in the UK?

The biggest misconception: tirzepatide is not freely available online

A lot of people searching for how to get tirzepatide assume that finding a website selling it means it is legal to buy without further checks. That is not the case. Tirzepatide is a Prescription-Only Medicine under the Human Medicines Regulations 2012, which means a registered prescriber must assess your health, confirm suitability, and issue a prescription before any supply is lawful. No legitimate pharmacy (online or on the high street) can skip that stage.

The MHRA has raised serious concerns about sellers offering GLP-1 medicines without a clinical assessment. In late 2025, enforcement teams seized around 20 million doses of illegally traded weight-loss medicines (roughly £45 million in street value), and the first illicit UK site producing counterfeit tirzepatide pens was raided in Northampton. Counterfeit pens have been found to contain insulin rather than tirzepatide, a potentially life-threatening substitution. One quick check anyone can do: look up any online pharmacy on the GPhC register before handing over any details. If it is not listed, do not proceed.

Understanding this distinction matters more than it might seem. The prescription requirement is not a formality, it exists because tirzepatide interacts with other conditions and medicines, and dosing is titrated over weeks by a clinician monitoring your response.

How you can actually get tirzepatide: the two routes in the UK

There are two legitimate pathways. The first is through the NHS, where tirzepatide (Mounjaro) is being introduced in carefully phased stages. NICE's appraisal of tirzepatide (TA1026) recommends it for adults with a BMI of 35 or above and at least one qualifying weight-related condition, though lower BMI thresholds apply for some ethnic backgrounds under UK guidance. NHS access began in June 2025 for those with a BMI of 40 or above alongside four or more of five specified conditions (high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, and type 2 diabetes), with further cohorts becoming eligible through 2026 and into 2027. Waiting lists vary considerably by area.

The second route is a private prescription through a GPhC-registered online pharmacy. This does not require a referral or an NHS waiting period, but it does require the same clinical rigour: a full health consultation, prescriber review, and verification steps. At nume, a GPhC-registered Independent Prescriber reads every consultation personally and on the same day, there is no automated decision-making involved. You can read more about our clinical approach on the clinical team page.

If you are weighing up costs alongside access, the context behind Mounjaro's UK pricing is worth understanding before you compare providers.

What eligibility actually looks like in practice

For a private prescription, the licensed eligibility criteria are set out in the Mounjaro Summary of Product Characteristics. Adults with a BMI of 30 or above qualify for assessment, as do those with a BMI of 27 or above if they have at least one weight-related condition, for example, prediabetes, hypertension, high cholesterol, or obstructive sleep apnoea. The NHS criteria for publicly funded treatment are narrower, as described above.

Meeting a BMI threshold is the starting point, not the finish line. A prescriber looks at your full medical history: existing conditions, current medicines, contraindications, and your goals. Tirzepatide is not suitable for everyone. It is not licensed for use in pregnancy, while breastfeeding, or when actively trying to conceive. It is not licensed for under-18s. Anyone with a history of medullary thyroid carcinoma or a condition called MEN2 should discuss this carefully with a clinician before considering any GLP-1 therapy.

Treatment starts at 2.5mg (a dose chosen to let your system adjust gradually) and is titrated by your prescriber in stages, and if you have questions about safety margins during titration, our page on whether you can overdose on tirzepatide covers what the clinical evidence shows. The full picture of how tirzepatide works and what the clinical evidence shows is covered in detail on the tirzepatide information page. For a broader overview of the medicine as licensed in the UK, the NHS tirzepatide page is a reliable starting point.

A note on other forms and related medicines

Some people ask whether they can get tirzepatide as a tablet rather than an injection. Currently, the only UK-licensed form of tirzepatide for weight management is the once-weekly subcutaneous injection (Mounjaro KwikPen). There is no licensed oral tirzepatide product available in the UK as of summer 2026. For people who are needle-averse, it is worth knowing that an oral GLP-1 option does now exist (the Wegovy tablet (oral semaglutide) received MHRA approval in June 2026) though that is a different medicine entirely. You can find more detail on whether tirzepatide comes in pill form if that is your main question.

It is also common to see tirzepatide confused with semaglutide (Wegovy, Ozempic) or to see the US brand name Zepbound mentioned in search results. Zepbound does not exist as a UK product; tirzepatide is sold here solely as Mounjaro. Ozempic is semaglutide licensed for type 2 diabetes, not weight loss. These distinctions matter when you are trying to work out what a legitimate UK prescription actually covers, and our guide to tirzepatide licensing in the UK sets out exactly what applies here. Our Mounjaro overview sets out the UK picture clearly, and the weight-loss treatments page compares the options licensed here.

If you think you may be eligible and would like a clinical assessment, you are welcome to speak to our prescribers through a free consultation, no referral needed, and no obligation.